Buy PT-141 (Bremelanotide) 5mg

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist that acts centrally in the brain to enhance sexual desire and arousal. Unlike PDE5 inhibitors (Viagra, Cialis) that work peripherally on blood flow, PT-141 activates the MC3R and MC4R receptors in the hypothalamus — the brain centers that regulate sexual motivation. This is why PT-141 works for both men and women across different etiologies of sexual dysfunction.

▸FDA Approval and Clinical Evidence

PT-141 was approved as Vyleesi (bremelanotide) in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women. The RECONNECT trials demonstrated significant improvements in sexual desire and distress in 25% of treated women versus 17% placebo — a statistically significant effect through an entirely novel mechanism.

▸Central vs Peripheral Mechanism

The distinction from conventional sexual function medications is clinically significant: PT-141 works regardless of whether blood flow is impaired, making it effective where PDE5 inhibitors fail. It also generates genuine subjective desire — a psychological and neurological effect rather than a purely physical one.

▸5mg Starter Vial

At 1.75mg per dose (the FDA-approved dose for HSDD), a 5mg vial provides approximately 2-3 doses — ideal for assessing individual response before committing to the 10mg vial.